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Abstract
Background: The number of middle-aged working individuals being diagnosed with cancer is increasing and so
too will disruptions to their employment. The aim of the Working After Cancer Study is to examine the changes to
work participation in the 12 months following a diagnosis of primary colorectal cancer. The study will identify
barriers to work resumption, describe limitations on workforce participation, and evaluate the influence of these
factors on health-related quality of life.
Methods/Design: An observational population-based study has been designed involving 260 adults newly-
diagnosed with colorectal cancer between January 2010 and September 2011 and who were in paid
employment at the time they were diagnosed. These cancer cases will be compared to a nationally
representative comparison group of 520 adults with no history of cancer from the general population. Eligible
cases will have a histologically confirmed diagnosis of colorectal cancer and will be identified through the
Queensland Cancer Registry. Data on the comparison group will be drawn from the Household, Income and
Labour Dynamics in Australia (HILDA) Survey. Data collection for the cancer group will occur at 6 and 12
months after diagnosis, with work questions also asked about the time of diagnosis, while retrospective data on
the comparison group will be come from HILDA Waves 2009 and 2010. Using validated instruments
administered via telephone and postal surveys, data will be collected on socio-demographic factors, work status
and circumstances, and health-related quality of life (HRQoL) for both groups while the cases will have
additional data collected on cancer treatment and symptoms, work productivity and cancer-related HRQoL.
Primary outcomes include change in work participation at 12 months, time to work re-entry, work limitations
and change in HRQoL status.
Discussion: This study will address the reasons for work cessation after cancer, the mechanisms people use to
remain working and existing workplace support structures and the implications for individuals, families and
workplaces. It may also provide key information for governments on productivity losses.
Study Registration: Australian and New Zealand Clinical Trial Registry No. ACTRN12611000530921
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Although cancer is often seen as a disease afflicting
older people, each year in Australia over 40,000 cancers,
or 43% of all cancers, are diagnosed in middle-aged peo-
ple of working ages (45-64 years) [1] and the number of
survivors living with cancer is increasing [2]. Conse-
quently, research attention has turned to assessing
health-related quality of life (HRQoL) and survivorship
issues after a diagnosis of cancer.
One survivorship issue that is not well quantified is
work participation and workplace issues after a diagno-
sis of cancer. Work can define a person’ss e l f - w o r t h ,
identity and social purpose, and it contributes to finan-
cial security. A cancer experience that causes major dis-
ruption in the work role can become a source of high
distress in addition to expensive medical bills, and can
adversely affect HRQoL [3,4]. Inability to work may
deprive an individual of stimulation, social contacts and
independence, while staying in or returning to work
after cancer treatment may be important for patients in
maintaining a sense of normalcy and control [3,4]. Can-
cer treatments are improving and current treatments
can involve prolonged periods of adjuvant therapy thus
previous reports on the extent of disruption to work
roles, earnings and other role activities may be outdated.
Lengthy treatments, ongoing medical care or the experi-
ence of a recurrence may lead to reduced career options
and loss of employment. Calls have therefore been made
for oncology health workers to better recognise and
screen patients for work-related distress [4].
Studies have shown between 30-93% of workers with
cancer will return to work [5,6], with most people
returning to work within 12 months of taking leave
[5,6]. Survivors of head and neck cancer and breast
cancer have shown more difficulty returning to work
than survivors of other cancer types [5-7]. Although
many people appear to resume their employment with
minimal interference [8,9], there may also be difficult
work re-entry, forced retirement, workplace discrimi-
nation and refusal of insurances [10]. Factors that have
been linked with delayed return to, or stopping work
include: older age [6,11,12]; physically-demanding work
[5,6,9,12]; being female [5,6,11,12]; presence of comor-
bidities [5]; being married [6,11]; fatigue [13]; lower
education [6,14]; chemotherapy [11]; blue collar occu-
pations [11]; and upper-body limitations [9]. Amongst
those who return to work, work disabilities are more
common for those with a physically demanding job,
advanced cancer stage and those experiencing treat-
ment side-effects [4]. However, many of these studies
are US-based and subject to a system of employment-
based health insurance and the added pressure on indi-
viduals to keep working to retain access to health care
services.
Current research concentrates on breast cancer survi-
vors so the relevance for other cancer populations is
unclear. A population-based cohort study of Australian
colorectal cancer survivors assessed a subset of working
adults for changes in work participation [15]. Twelve
months after diagnosis, 33% of men (n = 621) and 40%
of women (n = 354) were not working. Radiation ther-
apy among men (OR = 1.90, 95%CI: 1.14- 3.17) and che-
motherapy among women (OR = 1.87, 95%CI: 0.98-3.57)
were associated with a higher prevalence of work cessa-
tion [15]. The risk of ceasing work among women was
smaller if they had private health insurance (OR = 0.54,
95%CI: 0.31-0.92). Quality of life scores for persons who
stopped working were significantly lower than for per-
sons who continued working, after adjusting for addi-
tional explanatory factors [15]. However, this study was
limited because there was no non-cancer comparison
group and therefore was unable to determine the pro-
portion of cases who would have ceased work irrespec-
tive of cancer.
This paper presents the protocol of a population-
based observational study to examine the work experi-
ences in adults with colorectal cancer. We aim to
describe changes in work participation at two points in
time within a 12-month period, identify the key predic-
tors influencing work participation and time to work re-
entry, quantify the extent of physical and cognitive lim-
itations at work and the role of work on HRQoL. The
results of the study will provide valuable information for
individuals facing cancer, health professionals, suppor-
tive care services and government about the reasons for
work cessation, the mechanisms people use to remain
working and existing workplace support structures.
Methods
Study design
A longitudinal population-based study has been
designed to enrol middle-aged (45-64 years) men and
women newly-diagnosed with colorectal cancer who
were working at the time they were diagnosed. These
participants will be matched by gender and 5-year age
group to a nationally representative sample of men and
women from the general population. Participants in
both groups will be followed over 12-months and have
data collected on socio-demographic factors, work-
related factors, and HRQoL while the cancer sample will
have additional data collected on cancer treatment and
symptoms, work productivity and cancer-related
HRQoL.
Aims and hypotheses
The key aims of the study are to:
1. Describe transitions in employment participation
following a primary diagnosis of colorectal cancer within
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cancer;
2. Identify the key factors influencing work participa-
tion during or after cancer treatment compared to indi-
viduals without cancer;
3. Identify the key factors influencing time to work re-
entry after cancer treatment among individuals taking
work leave for their cancer treatment;
4. Investigate the influence of changes in employment
participation over a 12-month period on HRQoL at time
2 among individuals with cancer compared to those
without cancer; and
5. Quantify the extent of physical and cognitive limita-
tions at work (work disability) in individuals following a
primary diagnosis of colorectal cancer.
We hypothesise that:
1. The proportion of middle-aged working adults with
a primary diagnosis of colorectal cancer who substan-
tially alter their work hours (i.e. by ≥20%) or stop work-
ing by 12 months after diagnosis will be more than 15%
higher than among middle-aged working adults in the
general community;
2. The key barriers to work participation or timely
work re-entry after cancer will include regional or meta-
static cancer at diagnosis, age, fatigue at six months,
adjuvant therapy, living with an employed partner, lim-
ited work autonomy and low income; and,
3. Study participants who substantially reduce their
work hours or leave the work force against their choice,
will have clinically lower HRQoL scores at 12 months
compared to those who remain employed at 12 months.
Study participants
Eligible cases will be Queensland residents, aged 45-64
years, with a histologically confirmed diagnosis (notified
to the Queensland Cancer Registry (QCR)) of primary
colorectal cancer between January 2010 and September
2011, and in paid employment at the time of their can-
cer diagnosis. The QCR has universal coverage of per-
sons diagnosed with cancer residing in Queensland.
Study exclusions include: cognitive impairment; not
speaking English; having no telephone; and previous or
concurrent cancers (except non-melanoma skin cancer).
A general population comparison group will be ran-
domly selected from a secondary data source, the
Household, Income and Labour Dynamics in Australia
(HILDA) Survey dataset, using retrospective data in
Waves 9 and 10 (2009 and 2010 data). HILDA is an
Australian household panel survey which began in 2001
and collects information about economic and subjective
well-being (including HRQoL), labour market and family
dynamics. Households and individuals are followed up
annually through interviews and self-administered ques-
tionnaires. Each new survey wave of HILDA, is
developed and pilot-tested over a 9-month period using
a sample of urban and rural households prior to data
collection.
Ethics approval for the study was obtained from the
Human Ethics Research Committees of Queensland Insti-
tute of Medical Research, Griffith University and the
Queensland Health Research Ethics and Governance Unit.
Sample size
Based on cancer incidence [16] and labour figures [17] it
is anticipated that at least 522 working persons with col-
orectal cancer will be eligible annually. Sample size cal-
culations were based on the number required to detect
a 15% difference in work participation between workers
with and without cancer assuming a 5% significance
level and 80% power. Based on our past experience of
recruiting colorectal cancer patients through the QCR
and allowing for 85% doctors consent, 70% participant
consent, 90% baseline interview completions and 75%
retention at 12 months post-diagnosis, we will require
initial contact with 258 patients with colorectal cancer
to retain 125 patients at 12 months. The wave-on-wave
attrition rates among continuing HILDA respondents
have been consistently low, approximately 5% each year
[18]. Data for 2,590 employed persons enrolled in
HILDA aged 45-64 years Australia-wide will be avail-
able. HILDA data will be randomly matched 2:1 to
patients with colorectal cancer, by gender and 5-year
age category. Thus the total sample size to be selected
for the study will be approximately 780.
Recruitment
As mandated by QCR protocols, patients’ names and the
names of their doctors will be accessed via the QCR and
initial letters sent to each patient’sd o c t o rr e q u e s t i n g
permission for the patient to be approached, followed
by reminder letters and telephone calls if necessary. All
patients for whom doctor’s consent is obtained will be
mailed a study invitation letter, an information sheet
and consent form. Three weeks after the initial patient
letter, non-responders will be telephoned to gauge their
interest in the study and screened for their eligibility.
Data collection sources
Data will be collected during this project from four
sources (Table 1):
1) Pathology reports held within the QCR (cancer group)
Clinical data will be collected including tumour site, his-
topathological tumour type, degree of differentiation/
grade, degree of metastasis and stage of disease (e.g,
TNM or Dukes staging).
2) Telephone interviews (cancer group)
Participants with cancer will take part in structured tele-
phone interviews at 6 and 12 months after diagnosis. At
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participants to recall work-related information at the
time they were diagnosed with cancer (baseline). Tele-
phone interviews will be undertaken in order to maxi-
mise response rates, reach a wide geographical region
and minimise participant burden, the latter being impor-
tant in a working population that may require out-of-
hours contact. Interviews will be conducted by trained
and experienced interviewers. To minimise respondent
burden, interviews will be kept to approximately 30
minutes each. A flexible interview schedule will be
adopted and tailored to suit the schedules of working
participants.
3) Self-administered mailed questionnaire (cancer group)
To supplement the data collected from the telephone
interview, and to address items of a more sensitive nat-
ure (e.g., financial strain, health behaviours), additional
postal surveys will be sent to participants with cancer
immediately after the telephone interview. The surveys
will take approximately 20 minutes to complete.
4) General-population (comparison group) survey data
Secondary data from HILDA survey waves 9 and 10
(2009 and 2010 data) will be used to assess the compari-
son group. These data are collected by face-to-face
interviews.
Specific questionnaire items and measures
Generic baseline socio-demographic informationfor the
cancer and comparison groups will include items on
age, gender, education level, country of birth, culture,
marital status, household income, health and other
insurances, postcode of residence, number and age of
children.
Participants’ work situations, generic HRQoL, health
behaviours and conditionswill be collected at both time-
points (Table 1) with identical items for the cancer and
comparison groups. Work situation items include a
compilation of validated tools from Australian govern-
ment surveys (eg Australian Bureau of Statistics (ABS)
Labour Force Survey, ABS 19 9 9S u r v e yo fL i v i n gS t a n -
dards) and ask about: employment status, usual and pre-
ferred weekly hours, reasons for working part time,
occupation, occupation change, industry, trade union
membership, paid sick leave, paid holiday leave,
expected resignation or dismissal, supervisory responsi-
bilities, employer type, workplace size, job satisfaction, if
the respondent has a disability, type of disability, disabil-
ity commenced in the last year, impact of disability on
work probability, financial strain (e.g., access to emer-
gency funds, bills paid late), intended age of retirement
and intentions of stopping work during next three years.
Generic HRQoL will be evaluated using the widely-used
and validated Medical Outcomes Survey Short Form
(SF-36). Physical activity estimates will be obtained via
the International Physical Activity Questionnaire (short-
form) [19]. Other standard health behaviours and condi-
tions (smoking, alcohol consumption, height, weight and
chronic illnesses) will also be asked.
Cancer treatments, symptoms, cancer-specific HRQoL
and work limitation itemswill be collected at both time-
points for participants in the cancer group (Table 1).
The Memorial Symptom Assessment Scale (MSAS) will
be used as our measure of prevalence and severity of
common cancer treatment and disease symptoms [20].
This instrument has proven validity and reliability
among a sample comprising persons with prostate,
breast, colon and ovarian cancers [20]. Cancer-specific
HRQoL will be assessed using the Functional Assess-
ment of Cancer Therapy general questionnaire (FACT-
G) plus the colorectal cancer module; (FACT-C). The
FACT-G (Version 4) is a 36-item questionnaire with
four subscales: physical; social; emotional; and functional
well-being. The FACT-C has demonstrated validity and
reliability, is brief and sensitive to changes in functional
status [21]. In addition, Queensland general-population
norms are available to use for comparisons [22]. The
25-item Work Limitations Questionnaire (WLQ) will be
used to assess potential difficulties experienced at work
Table 1 Questionnaire item domains at each time point by cancer cases and general-population comparison group
Cancer Group Comparison Group
Method Telephone interview Mailed questionnaire Face-to-face interview
Time 1
a 1. Socio-demographics
b
2. Cancer treatments
3. Symptoms (MSAS
b)
4. Work questions
a
5. Work limitations (WLQ)
6. Quality of life (SF-36)
b
7. Health behaviours & conditions
b
8. Cancer-specific quality of life (FACT-C)
9. Financial strain
b
Question groups 1, 4, 6, 7, 8, 9 from HILDA Wave 9, 2009 data
Time 2 Repeat question groups 2-8 Question groups 1, 4, 6, 7, 8 from HILDA Wave 10, 2010 data
a Time 1 for the Cancer Group occurs six-months after diagnosis however retrospective work questions are asked about their time of diagnosis (baseline) and
about their current time (six months after diagnosis) therefore a common one year period will be compared across the cancer and comparison groups for key
work questions.
bThese questions are the same as those in the comparison group to enable direct comparison between groups.
Abbrevs: FACT-C = Functional Assessment in Cancer Therapy plus Colorectal Cancer module, HILDA = Household, Income and Labour Dynamics in Australia,
MSAS = Memorial Symptom Assessment Scale, SF-36 = Medical Outcomes Study Short Form 36, WLQ = Work Limitations Questionnaire.
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ment, physical demands of work, mental-interpersonal
demands (cognitive job tasks, on-the-job social interac-
tions) and output demands (diminished work quantity
and quality). The WLQ has strong psychometric proper-
ties and has tested in patients with various chronic dis-
eases [23].
Analyses
All analyses will include gender as a factor and will
test for interactions of gender with other factors in the
model. Gender differences are important, as not only
do men and women have different work participation
rates, work hours and occupation types in the general
population [17], they respond and adjust differently to
illnesses, have different health behaviours and other
risk factors for cancer [24]. Where no effect modifica-
tion is observed, pooled results will be presented.
Socio-demographic characteristics will be compared at
baseline to identify any statistically significant differ-
ences between the cancer and comparison groups.
Descriptive analyses will be conducted to chart
employment transitions over the year since diagnosis
among the cancer group and over 2009-2010 year per-
iod among the comparison group. Although the first
time point for the cancer group is six months after
diagnosis, participants are asked to recall work circum-
stances (occupation type, hours worked, industry etc)
at the time of diagnosis (retrospectively) and at time 1
(six months after diagnosis). Separate multivariable
logistic regression modelling will identify explanatory
variables that are significantly associated with work
participation in the cancer and comparison groups. For
these models, adjusted odds ratios with 95% confidence
intervals and p-values will be computed. Cox propor-
tional hazards models will assess time to work resump-
tion in the participants with cancer and significant
correlates of timely work re-entry. Mixed-effects mod-
elling for the cancer group will be used to examine
change in HRQoL scores (time 1 - time 2) by partici-
pants who reduce or leave in that time versus those
w h od on o t .W ew i l la l s oc o m p a r eH R Q o Ls c o r e s
between the cancer and comparison groups at time 2.
Data on work limitations measured in the cancer
group will be scored across the four domains and
mixed-effects modelling undertaken to assess changes
in scores between time 1 and time 2. Reasons for
study withdrawal in the cancer sample will be closely
monitored. Descriptive analyses of baseline variables
for the ‘completers’ and ‘non-completers’ will identify
any possible bias and the source and, if necessary, sub-
sequent analyses will be weighted accordingly. In the
comparison group, only responders at both HILDA
Waves 9 and 10 will be included.
We expect the relationship between work participation
and HRQoL to be complex and therefore, to comple-
ment the analyses above, statistical modelling will be
undertaken to allow for health status to be an endogen-
ous component of work participation. We will address
this using the estimation of two-stage simultaneous pro-
b i tl e a s ts q u a r e s[ 2 5 ] .U n l i k ep r e v i o u sa n a l y s e se x a m i n -
ing the relationship between health status and work
participation [25,26] in patients with chronic illness, we
will have comprehensive clinical data to describe disease
status in addition to self-reported health status. STATA
SE (Version 11.0) will be used for all analyses. Written
reports of the study findings will adhere to the STROBE
(Strengthening the Reporting of Observational studies in
Epidemiology) statement for quality purposes.
Discussion
Despite the considerable number of Australians of work-
ing ages being diagnosed with cancer each year, surpris-
i n g l yl i t t l ei sk n o w na b o u tt he impact of cancer on the
workforce. With an ageing population, the Australian
Government has recently implemented policies to
encourage people to remain working longer and has
increased access to personal superannuation funds and
social security benefits (e.g. pension bonus schemes).
The challenges presented to ‘baby boomers’ (those born
during 1946-1961) differ from those facing previous
generations because, as they approach normal retire-
ment age, they may face caring responsibilities for both
elderly parents and young grandchildren [27]. Female
baby boomers may be disadvantaged financially due to
working in occupations that were traditionally low-paid
and female-dominated (i.e., nursing, secretarial, retail,
teaching) and before equal pay legislation (pre-1960s)
and compulsory superannuation laws. They may also
have taken longer periods off work to raise families,
compared to subsequent generations, and so collectively
may have little retirement savings and financial security
[27]. Middle-aged men with cancer may be at the height
of their careers, and their sense of self may be strongly
attached to their work roles. Therefore, cancer may
negatively affect a person’s employment and financial
situation and fuel the anxiety and distress created from
facing a life-threatening illness.
Our research will extend the current literature and
improve our understanding in this field. The translation
of current knowledge into supportive care practice is
limited because of the use of retrospective or cross-sec-
tional designs and/or, patient groups from a single clini-
cal setting, a dominance of breast cancer among the
patient samples and, importantly, the inability to isolate
the effects of ageing, retirement choice and labour force
changes due to the lack of a non-cancer control group.
Our study will overcome these limitations by recruiting
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ments, including a non-cancer comparison group and
utilising both a prospective and retrospective design. We
have chosen colorectal cancer because this cancer type
is the most common to both men and women, and we
will have a homogenous disease group from which to
compare men and women.
The study will address an important issue in cancer sur-
vivorship in greater detail than previously reported and, in
doing so, will provide further insights into living with can-
cer and the potential implications for individuals, families
and workplaces. It will also advance methods in economic
evaluations of health care where a better understanding of
productivity losses is gaining importance. Further, this
project will identify specific issues and barriers faced by
cancer survivors who want to remain employed, and pro-
vide practical information to supportive cancer care provi-
ders able to directly translate this information into
developing resources for newly diagnosed cancer patients.
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